Adri C Voogd Selected Research

Adri C Voogd Research Topics

Disease

49	Breast Neoplasms (Breast Cancer) 05/2024 - 03/2002
34	Neoplasms (Cancer) 01/2024 - 11/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 06/2013 - 07/2008
3	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2022 - 05/2021
3	Neoplasm Metastasis (Metastasis) 06/2019 - 04/2012
2	Triple Negative Breast Neoplasms 01/2024 - 01/2022
2	Margins of Excision 10/2021 - 01/2017
2	Lymphedema (Milroy Disease) 06/2015 - 04/2013
2	Pain (Aches) 07/2014 - 03/2002
2	Chromosomal Instability (Chromosome Stability) 04/2014 - 04/2013
2	Neoplasm Micrometastasis 08/2012 - 05/2011
2	Carcinogenesis 12/2010 - 10/2009
1	Ductal Carcinoma 07/2017
1	Lobular Carcinoma 07/2017
1	Breast Cancer Lymphedema 07/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Cardiotoxicity 01/2016
1	Postoperative Pain 07/2014
1	Lymphatic Metastasis 10/2011
1	Unilateral Breast Neoplasms 10/2011
1	Inflammation (Inflammations) 07/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2009
1	Carcinoma (Carcinomatosis) 05/2009

Drug/Important Bio-Agent (IBA)

9	Hormones (Hormone)IBA 09/2022 - 12/2011
5	Estrogen ReceptorsIBA 05/2024 - 11/2002
5	EnzymesIBA 01/2016 - 07/2009
4	Trastuzumab (Herceptin)FDA Link 10/2017 - 07/2013
3	AnthracyclinesIBA 02/2017 - 04/2013
3	Taxoids (Taxanes)IBA 02/2017 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2009
2	Aromatase InhibitorsIBA 01/2023 - 08/2010
2	Tamoxifen FDA LinkGeneric 01/2023 - 08/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2017 - 11/2002
2	Progesterone FDA LinkGeneric 07/2017 - 11/2002
2	Estrogens (Estrogen)FDA Link 07/2017 - 11/2002
2	human ERBB2 proteinIBA 08/2015 - 10/2013
2	Cyclin D1IBA 04/2014 - 05/2009
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Formaldehyde (Formol)FDA Link 01/2024
1	ParaffinIBA 01/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2019
1	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2017
1	Dihydrotachysterol (AT 10)IBA 04/2016
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Bevacizumab (Avastin)FDA Link 07/2013
1	Indicators and Reagents (Reagents)IBA 04/2013
1	DNA ProbesIBA 04/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2013
1	taxaneIBA 04/2013
1	UGT1A1 enzymeIBA 12/2010
1	Hemoglobins (Hemoglobin)IBA 12/2010
1	BilirubinIBA 12/2010
1	AntioxidantsIBA 12/2010
1	Waste Products (Waste Product)IBA 12/2010
1	CarcinogensIBA 10/2009
1	SmokeIBA 10/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2009
1	ProstaglandinsIBA 07/2009
1	ThromboxanesIBA 07/2009
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2009
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2009
1	Cell Cycle ProteinsIBA 05/2009
1	Epoxide HydrolasesIBA 07/2008

Therapy/Procedure

18	Therapeutics 01/2023 - 05/2007
14	Segmental Mastectomy (Lumpectomy) 05/2024 - 03/2002
11	Radiotherapy 05/2024 - 07/2003
10	Mastectomy (Mammectomy) 09/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 01/2024 - 07/2006
8	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 06/2012
5	Adjuvant Chemotherapy 01/2022 - 12/2011
4	Neoadjuvant Therapy 11/2018 - 04/2012
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2021 - 10/2011
1	AC protocol (CA protocol) 10/2021
1	Re-Irradiation 06/2021
1	Mammaplasty (Breast Reconstruction) 07/2016
1	Compression Stockings 07/2014
1	Laser Therapy (Surgery, Laser) 07/2014
1	Palliative Care (Palliative Therapy) 02/2010
1	Aftercare (After-Treatment) 01/2007